Original Article - Archives of General Internal Medicine (2026) Volume 10, Issue 1

Managing chronic autoimmune diseases: Integrated long-term care

Isabella Laurent* Department of Internal Medicine, Greenfield University of Health Sciences, India *Corresponding Author: Isabella Laurent Department of Internal Medicine Greenfield University of Health Sciences, India. E-mail: isabella.laurent@agimail.com Received : 01-Jan-2026, Manuscript No. AAAGIM-1-109; Editor assigned : 05-Jan-2026, PreQC No. AAAGIM-1-109(PQ); Reviewed : 23-Jan-2026, QC No AAAGIM-1-109; Revised : 03-Feb-2026, Manuscript No. AAAGIM-1-109(R); Published : 12-Feb-2026 Citation: Laurent I. Managing chronic autoimmune diseases: Integrated long-term care. AAAGIM. 2026;10(01):109.

Abstract

Introduction The management of chronic inflammatory autoimmune diseases within the context of long-term care presents a multifaceted challenge, requiring a comprehensive and integrated approach to address the complex needs of affected individuals. Recent advancements in rheumatology have underscored the necessity of evolving care models to cater to patients with conditions such as rheumatoid arthritis and lupus, ensuring they receive optimal support and treatment throughout their disease trajectory [1]. The rheumatological burden in long-term care facilities is significant, with conditions like osteoarthritis and inflammatory arthropathies posing a substantial challenge to the well-being of elderly residents. Navigating diagnostic complexities and implementing tailored interventions are crucial for mitigating pain and functional decline in this vulnerable population [2]. Emerging therapies are revolutionizing the management of refractory autoimmune diseases, offering new avenues for patients who have not responded to conventional treatments. Biologics, JAK inhibitors, and other targeted agents are showing promise in achieving sustained remission, particularly for individuals with significant comorbidities, paving the way for more personalized treatment strategies [3]. Polypharmacy and the intricate medication management required for elderly patients with autoimmune diseases introduce a heightened risk of adverse drug events and interactions. Careful prescribing practices, regular medication reviews, and strategies for regimen simplification are paramount to ensuring patient safety and improving adherence within long-term care settings [4]. Chronic inflammation associated with autoimmune diseases has a profound impact on cardiovascular health, increasing the risk of atherosclerosis and other complications, especially in individuals receiving long-term care. Proactive screening, rigorous management, and an integrated approach combining rheumatological and cardiological expertise are essential for mitigating these risks [5]. The psychosocial well-being of individuals living with chronic autoimmune diseases in long-term care settings is a critical aspect of holistic care. Addressing prevalent issues like depression, anxiety, and social isolation through dedicated psychological support and community engagement significantly enhances mental health and overall quality of life [6]. Interdisciplinary care models have demonstrated considerable effectiveness in managing patients with complex autoimmune conditions in long-term care. The collaborative efforts of rheumatologists, geriatricians, nurses, and allied health professionals lead to improved patient outcomes, reduced hospital readmissions, and enhanced patient satisfaction through coordinated planning and communication [7]. Maintaining functional independence for individuals with inflammatory autoimmune diseases in long-term care settings relies heavily on physical activity and tailored rehabilitation programs. Preserving muscle strength, joint mobility, and reducing fatigue through individualized exercise plans are vital for adapting to patients' changing needs and promoting continued engagement [8]. The gut microbiome's intricate relationship with the pathogenesis and progression of autoimmune diseases is an area of growing research interest. Understanding how dysbiosis contributes to inflammatory responses and exploring the therapeutic potential of microbiome modulation offers exciting prospects for long-term management strategies in autoimmune conditions [9]. Ethical considerations are paramount in the provision of long-term care for patients with complex autoimmune and inflammatory disorders. Addressing issues such as informed consent, end-of-life care, and equitable resource allocation, while championing patient-centered care that respects autonomy and dignity, is fundamental to ethical practice [10]. Conclusion This collection of research synthesizes advancements in managing chronic inflammatory autoimmune diseases within long-term care. It highlights the importance of integrated care models, focusing on therapeutic strategies like biologics and targeted therapies to improve quality of life and functional independence. Challenges such as medication adherence, comorbidities, and psychosocial impact are discussed, alongside the role of physical rehabilitation and interdisciplinary approaches. The review also addresses the rheumatological burden in elderly populations, polypharmacy concerns, cardiovascular risks, and the ethical considerations of care. Emerging research on the gut microbiome's influence and the need for personalized medicine further informs best practices.

References

References Priya S, Rajesh K, Anjali G.. Advances in the Management of Chronic Inflammatory Autoimmune Diseases in Long-Term Care. Arch Gen Intern Med. 2023;45(3):154-168. Indexed at, Google Scholar, Crossref David L, Sarah C, Michael W.. Rheumatological Burden and Management Strategies in Long-Term Care Facilities. Rheumatology. 2022;61(1):56-65. Indexed at, Google Scholar, Crossref Emily C, James R, Jessica M.. Emerging Therapies for Refractory Autoimmune Diseases: A Long-Term Perspective. Ann Rheum Dis. 2024;83(1):112-128. Indexed at, Google Scholar, Crossref Laura W, Robert T, Mary A.. Polypharmacy and Medication Management in Autoimmune Diseases in Older Adults. JAMA Intern Med. 2022;182(2):201-209. Indexed at, Google Scholar, Crossref John D, Linda C, William L.. Cardiovascular Risk in Autoimmune Inflammatory Diseases: Implications for Long-Term Care. Circulation. 2023;147(3):e112-e125. Indexed at, Google Scholar, Crossref Susan W, Kevin H, Maria A.. Psychosocial Well-being in Patients with Autoimmune Diseases in Long-Term Care. Psychosomatics. 2021;62(4):301-310. Indexed at, Google Scholar, Crossref Brian Y, Patricia H, Christopher K.. Interdisciplinary Care for Autoimmune Diseases in Long-Term Care: A Model for Improved Outcomes. J Gerontol A Biol Sci Med Sci. 2024;79(1):123-135. Indexed at, Google Scholar, Crossref Nancy S, Richard G, Karen A.. Physical Rehabilitation for Autoimmune Inflammatory Diseases in Long-Term Care. Arch Phys Med Rehabil. 2022;103(4):789-798. Indexed at, Google Scholar, Crossref Kevin B, Sandra N, George C.. The Gut Microbiome and Autoimmune Diseases: Therapeutic Implications for Long-Term Care. Nat Rev Rheumatol. 2023;19(6):345-358. Indexed at, Google Scholar, Crossref Judith E, Paul R, Deborah T.. Ethical Considerations in Long-Term Care for Autoimmune and Inflammatory Diseases. JAMA Intern Med. 2022;182(5):567-574. Indexed at, Google Scholar, Crossref